Asia PDL1 Study Among NSCLC Patients

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

NCT02622581 ·Status: RECRUITING

PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer

NCT05533086 ·Status: UNKNOWN

The Research Plan of Taiwan Precision Medicine

NCT04849481 ·Status: RECRUITING

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

NCT06842056 ·Status: NOT_YET_RECRUITING

An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy

NCT00721981 ·Status: TERMINATED

Immune-Marker Platform for Patients With Advanced Lung Cancer

NCT07150598 ·Status: NOT_YET_RECRUITING

A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

NCT04312308 ·Status: COMPLETED

Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)

NCT05094882 ·Status: UNKNOWN

Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy

NCT05636605 ·Status: RECRUITING

Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

NCT07215026 ·Status: COMPLETED

A Prospective Epidemiologic Study of ALK-Positive NSCLC in China

NCT02042105 ·Status: COMPLETED

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.

NCT02785562 ·Status: COMPLETED ·Phase: NA

PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer

NCT02827344 ·Status: COMPLETED

Establishment and Characterization of Patient-Derived Non-Small Cell Lung Cancer Xenografts and Cell Cultures

NCT01130571 ·Status: UNKNOWN

Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

NCT07331701 ·Status: NOT_YET_RECRUITING

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

NCT06443684 ·Status: RECRUITING

PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot Study

NCT05222087 ·Status: RECRUITING ·Phase: PHASE1

Primary Radiotherapy In MEtastatic Lung Cancer

NCT07135882 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

NCT04749407 ·Status: UNKNOWN

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

NCT02758314 ·Status: UNKNOWN

PD-L1 Expression in Lung Cancer

NCT04992715 ·Status: UNKNOWN ·Phase: PHASE2

Obstructive Sleep Apnea Influences Efficacy of PD-1-Based Immunotherapy Against Non-Small Cell Lung Cancer

NCT04743752 ·Status: RECRUITING

Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer

NCT04827667 ·Status: UNKNOWN

Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer

NCT03505515 ·Status: COMPLETED

Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil

NCT04947683 ·Status: COMPLETED